S.C. Code Ann. § 40-47-65 – Restrictions on dispensing amphetamine substances

(1) Amphetamine, methamphetamine, phenmetrazine, their salts and isomers, as identified in Section 44-53-210, Schedule II, hereafter referred to as "the assigned drugs", shall not be dispensed or prescribed except as provided in this section. A departure from these provisions is deemed to constitute an act of professional misconduct subject to discipline under Section 40-47-200.
(2) A physician, medical or osteopathic, shall not dispense or prescribe the assigned drugs without taking into account the high potential for abuse of such drugs, the possibility that such drugs may lead to severe psychic or physical dependence, the possibility that the patient will obtain the drug for a nontherapeutic use or distribution to others, and the existence of extensive abuse and an illicit market for such drugs. The physician shall note on his records the purpose for which the assigned drugs are prescribed. In no event shall there be a prescription for the purpose of treating obesity.
(3) The assigned drugs shall not be dispensed or prescribed in the treatment of a hyperkinetic child syndrome prior to the taking of a complete history and physical examination.
(4) A sufficient history and physical examination and appropriate diagnostic studies of a patient shall be taken to establish that the condition exists prior to dispensing or prescribing the assigned drugs in the treatment of narcolepsy. The findings upon which the diagnosis of narcolepsy was made shall be entered in the patient's record.
(5) A physician, medical or ostopathic, may apply for a written waiver of the requirements of this section by submitting a written request to the Board. The request shall include all information necessary for a comprehensive evaluation of its merit. If the physician, medical or ostopathic, requesting the waiver demonstrates to the satisfaction of the Board that a waiver would further legitimize medical purposes without undermining the purposes of this section, the Board may issue a written waiver with such terms and conditions as may be deemed appropriate.
(6) This section shall not be construed to endorse the use of the assigned drugs in the treatment of obesity nor shall it be construed to diminish a physician's, medical or ostopathic, responsibility to comply with those standards of medical practice in the dispensing or prescribing of the assigned drugs which are not set forth in this section.